Cap+Bev vs Cap+Iri+Bev 1st-line Therapy in mCRC

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2010 by Ludwig-Maximilians - University of Munich
Sponsor:
Collaborator:
Roche Pharma AG
Information provided by:
Ludwig-Maximilians - University of Munich
ClinicalTrials.gov Identifier:
NCT01249638
First received: November 29, 2010
Last updated: March 11, 2011
Last verified: November 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)
No publications provided by Ludwig-Maximilians - University of Munich

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):